Production of Radiopharmaceutical Medicinal Product 18F-Fluorodeoxyglucose
https://doi.org/10.37174/2587-7593-2018-1-3-10-14
Abstract
In the article considers modern commercial method of production is demanded used in oncology medical product radiopharmaceutical 18F-fluorodeoxyglucose (2-fluoro-18F-2-deoxy-D-glucose, 18F-FDG), are presented the process steps and operation of synthesis, quality control procedures, briefly described the requirements for packaging and labeling of radiopharmaceutical.
About the Authors
D. I. NevzorovRussian Federation
Moscow
I. A. Skripachev
Russian Federation
Moscow
M. B. Dolgushin
Russian Federation
Moscow
A. A. Odzharova
Russian Federation
Moscow
N. V. Eremin
Russian Federation
Moscow
References
1. Kam Leung. 2005. [18F]Fluoro-2-deoxy-2-D-glucose in Molecular Imaging and Contrast Agent Database (MICAD). National Center for Biotechnology Information, NLM, NIH, Bethesda, MD.
2. Zanoni L., Al-Sugair A.S., Fanti S. Clinical applications of 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography-computed tomography (PET/CT) // Nucl. Med. Rev. 2012. Vol. 15. Suppl. P. C48–C51.
3. Тулин П. Е., Долгушин М. Б., Патютко И. Ю. и соавт. ПЭТ/КТ с 18F-ФДГ и 18F-холином в диагностике смешанного гепатохолангиоцеллюлярного рака (клиническое наблюдение) // Диагн. и интервенц. радиол. 2015. Т. 9. № 1. C. 91–99.
4. Min-Fu Yang, Diwakar Jain, Zuo-Xiang He. 18F-FDG cardiac studies for identifying ischemic memory // Curr. Cardiovasc. Imaging Rep. 2012. Vol. 5. P. 383–389.
5. Ghesani M., Depuey E.G., Rozanski A. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability // Echocardiography. 2005. Vol. 22. № 2. P. 165–177.
6. Nose H., Otsuka H., Otomi Y. et al. Evaluation of normal physiologic left ventricular myocardial 18F-FDG uptake at fasting state // Europ. Congress of Radiol. 1-5 March, 2012. Vienna, Austria. URL: http://posterng.netkey.at/esr/viewing/index.php?module=viewing_poster&doi=10.1594/ecr2012/C-11922012.
7. Dong Soo Lee, Sang Kun Lee, Myung Chul Lee. Functional neuroimaging in epilepsy: FDG PET and Ictal SPECT // Korean Medю Sci. 2001. Vol. 16. P. 689–696.
8. Teune L.K., Bartels A.L., Leenders K.L. FDG-PET Imaging in neurodegenerative brain diseases // In: Functional Brain Mapping and the Endeavor to Understand the Working Brain. Ed. by F. Signorelli and D. Chirchiglia. 2013.
9. Sanchez-Catasus C.A., Vallez Garcia D., Le Riverend Morales E., Galvizu S.R. Traumatic brain injury // In: Nuclear Medicine Neuroimaging. PET and SPECT in Neurology, 2014. P. 923–946.
10. Masangkay N., Basu S., Moghbel M. et al. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings // Nucl. Med. Commun. 2014. Vol. 35. № 10. P. 1038–1046.
11. Jones S.C., Alavi A., Christman D. et al. The radiation dosimetry of 2-[F-18]fluoro-2-deoxy-D-glucose in man // J. Nucl. Med. 1982. Vol. 23. P. 613–617.
12. Ido T., Wan C.N., Fowler J.S. Fluorination with F2: convenient synthesis of 2-deoxy-2-fluoro-d-glucose // J. Org. Chem. 1977. Vol. 42. P. 2341–2342.
13. Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution // J. Nucl. Med. 1986. Vol. 27. P. 235–238.
14. Toorongian S.A., Mulholland G.K., Jewett D.M. et al. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin // Int. J. Rad. Appl. Instrum. B. 1990. Vol. 17. № 3. P. 273–279.
15. СанПиН 2.6.1.3288-15. Гигиенические требования по обеспечению радиационной безопасности при подготовке и проведении позитронной эмиссионной томографии.
16. Gomzina N.A., Vasil’ev D.A., Krasikova R.N. Optimization of automated synthesis of 2-[18F]Fluoro-2-deoxy-D-glucose involving base hydrolysis // Radiochemistry. 2002. Vol. 44. № 4. P. 403–409.
17. Gopal B. Saha. Basics of PET Imaging: Physics, Chemistry and Regulations. 3th ed. – New York: Springer International Publishing. 2016. 165 pp.
Review
For citations:
Nevzorov D.I., Skripachev I.A., Dolgushin M.B., Odzharova A.A., Eremin N.V. Production of Radiopharmaceutical Medicinal Product 18F-Fluorodeoxyglucose. Journal of oncology: diagnostic radiology and radiotherapy. 2018;1(3):10-14. (In Russ.) https://doi.org/10.37174/2587-7593-2018-1-3-10-14